Standout Papers

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection 2008 2026 2014 2020 560
  1. Maraviroc for Previously Treated Patients with R5 HIV-1 Infection (2008)
    Roy M. Gulick, Jacob Lalezari et al. New England Journal of Medicine

Immediate Impact

9 by Nobel laureates 18 from Science/Nature 64 standout
Sub-graph 1 of 24

Citing Papers

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity
2024 Standout
2 intermediate papers

Works of Caroline E. Ridgway being referenced

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection
2008 Standout
Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1
2005

Author Peers

Author Last Decade Papers Cites
Caroline E. Ridgway 937 1002 150 244 12 1.4k
Margo Heath‐Chiozzi 848 795 104 200 22 1.7k
Sandra Nusinoff-Lehrman 1117 906 105 246 14 1.8k
Robert Yarchoan 825 782 173 258 20 1.4k
N J Fitch 686 869 95 419 14 2.0k
Julie Mori 995 936 122 313 24 1.6k
Howard Mayer 1019 1150 94 276 15 1.7k
Jeffrey P. Nadler 1081 995 81 236 28 1.8k
Raquel Martínez 693 664 98 246 40 1.5k
Gabriela Bleiber 823 819 257 193 23 1.4k
Carla Pettinelli 1360 1019 87 100 11 1.8k

All Works

Loading papers...

Rankless by CCL
2026